475 related articles for article (PubMed ID: 19893616)
1. New dual mode gadolinium nanoparticle contrast agent for magnetic resonance imaging.
Ghaghada KB; Ravoori M; Sabapathy D; Bankson J; Kundra V; Annapragada A
PLoS One; 2009 Oct; 4(10):e7628. PubMed ID: 19893616
[TBL] [Abstract][Full Text] [Related]
2. T1 relaxivity of core-encapsulated gadolinium liposomal contrast agents--effect of liposome size and internal gadolinium concentration.
Ghaghada K; Hawley C; Kawaji K; Annapragada A; Mukundan S
Acad Radiol; 2008 Oct; 15(10):1259-63. PubMed ID: 18790397
[TBL] [Abstract][Full Text] [Related]
3. Pre-clinical evaluation of a nanoparticle-based blood-pool contrast agent for MR imaging of the placenta.
Ghaghada KB; Starosolski ZA; Bhayana S; Stupin I; Patel CV; Bhavane RC; Gao H; Bednov A; Yallampalli C; Belfort M; George V; Annapragada AV
Placenta; 2017 Sep; 57():60-70. PubMed ID: 28864020
[TBL] [Abstract][Full Text] [Related]
4. Multimodal Magnetic Resonance and Near-Infrared-Fluorescent Imaging of Intraperitoneal Ovarian Cancer Using a Dual-Mode-Dual-Gadolinium Liposomal Contrast Agent.
Ravoori MK; Singh S; Bhavane R; Sood AK; Anvari B; Bankson J; Annapragada A; Kundra V
Sci Rep; 2016 Dec; 6():38991. PubMed ID: 28004770
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral evaluation of 3D microvasculature and nanoparticle distribution using a gadolinium-dendron modified nano-liposomal contrast agent with magnetic resonance micro-imaging.
Nitta N; Takakusagi Y; Kokuryo D; Shibata S; Tomita A; Higashi T; Aoki I; Harada M
Nanomedicine; 2018 Jun; 14(4):1315-1324. PubMed ID: 29626524
[TBL] [Abstract][Full Text] [Related]
6. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
Chen Z; Yu D; Liu C; Yang X; Zhang N; Ma C; Song J; Lu Z
J Drug Target; 2011 Sep; 19(8):657-65. PubMed ID: 21091273
[TBL] [Abstract][Full Text] [Related]
7. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
[No Abstract] [Full Text] [Related]
8. High-resolution magnetic resonance angiography in the mouse using a nanoparticle blood-pool contrast agent.
Howles GP; Ghaghada KB; Qi Y; Mukundan S; Johnson GA
Magn Reson Med; 2009 Dec; 62(6):1447-56. PubMed ID: 19902507
[TBL] [Abstract][Full Text] [Related]
9. Magnetic Heating Stimulated Cargo Release with Dose Control using Multifunctional MR and Thermosensitive Liposome.
Ray S; Cheng CA; Chen W; Li Z; Zink JI; Lin YY
Nanotheranostics; 2019; 3(2):166-178. PubMed ID: 31183312
[No Abstract] [Full Text] [Related]
10. Gadolinium-containing copolymeric chelates--a new potential MR contrast agent.
Unger EC; Shen D; Wu G; Stewart L; Matsunaga TO; Trouard TP
MAGMA; 1999 Aug; 8(3):154-62. PubMed ID: 10504042
[TBL] [Abstract][Full Text] [Related]
11. Hepatic metastases: liposomal Gd-DTPA-enhanced MR imaging.
Unger EC; Winokur T; MacDougall P; Rosenblum J; Clair M; Gatenby R; Tilcock C
Radiology; 1989 Apr; 171(1):81-5. PubMed ID: 2928550
[TBL] [Abstract][Full Text] [Related]
12. Enhancing T
Marangoni VS; Neumann O; Henderson L; Kaffes CC; Zhang H; Zhang R; Bishnoi S; Ayala-Orozco C; Zucolotto V; Bankson JA; Nordlander P; Halas NJ
Proc Natl Acad Sci U S A; 2017 Jul; 114(27):6960-6965. PubMed ID: 28630340
[TBL] [Abstract][Full Text] [Related]
13. Redox ferrocenylseleno compounds modulate longitudinal and transverse relaxation times of FNPs-Gd MRI contrast agents for multimodal imaging and photo-Fenton therapy.
Zhou T; Zhang S; Zhang L; Jiang T; Wang H; Huang L; Wu H; Fan Z; Jing S
Acta Biomater; 2023 Jul; 164():496-510. PubMed ID: 37054962
[TBL] [Abstract][Full Text] [Related]
14. Smart thermosensitive liposomes for effective solid tumor therapy and in vivo imaging.
Affram K; Udofot O; Singh M; Krishnan S; Reams R; Rosenberg J; Agyare E
PLoS One; 2017; 12(9):e0185116. PubMed ID: 28934281
[TBL] [Abstract][Full Text] [Related]
15. Paramagnetic liposomes as MRI contrast agents: influence of liposomal physicochemical properties on the in vitro relaxivity.
Fossheim SL; Fahlvik AK; Klaveness J; Muller RN
Magn Reson Imaging; 1999 Jan; 17(1):83-9. PubMed ID: 9888401
[TBL] [Abstract][Full Text] [Related]
16. Nanotemplate-engineered nanoparticles containing gadolinium for magnetic resonance imaging of tumors.
Zhu D; Lu X; Hardy PA; Leggas M; Jay M
Invest Radiol; 2008 Feb; 43(2):129-40. PubMed ID: 18197065
[TBL] [Abstract][Full Text] [Related]
17. Synergy between surface and core entrapped metals in a mixed manganese-gadolinium nanocolloid affords safer MR imaging of sparse biomarkers.
Wang K; Pan D; Schmieder AH; Senpan A; Hourcade DE; Pham CT; Mitchell LM; Caruthers SD; Cui G; Wickline SA; Shen B; Lanza GM
Nanomedicine; 2015 Apr; 11(3):601-9. PubMed ID: 25652900
[TBL] [Abstract][Full Text] [Related]
18. Relaxivity of Gd-based contrast agents on X nuclei with long intrinsic relaxation times in aqueous solutions.
van Heeswijk RB; Laus S; Morgenthaler FD; Gruetter R
Magn Reson Imaging; 2007 Jul; 25(6):821-5. PubMed ID: 17448617
[TBL] [Abstract][Full Text] [Related]
19. Biocompatible nanotemplate-engineered nanoparticles containing gadolinium: stability and relaxivity of a potential MRI contrast agent.
Zhu D; White RD; Hardy PA; Weerapreeyakul N; Sutthanut K; Jay M
J Nanosci Nanotechnol; 2006 Apr; 6(4):996-1003. PubMed ID: 16736756
[TBL] [Abstract][Full Text] [Related]
20. Development of a novel lipidic nanoparticle probe using liposomal encapsulated Gd₂O₃-DEG for molecular MRI.
Zohdiaghdam R; Riyahi-Alam N; Moghimi HR; Haghgoo S; Alinaghi A; Azizian G; Ghanaati H; Gorji E; Rafiei B
J Microencapsul; 2013; 30(7):613-23. PubMed ID: 23915304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
